ID

31381

Descripción

Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

Palabras clave

  1. 31/7/18 31/7/18 -
  2. 18/8/18 18/8/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

18 de agosto de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593

Actual administered mCi Dose

Dosimetric Dose
Descripción

Dosimetric Dose

Alias
UMLS CUI-1
C4019308
Date dose administered
Descripción

Medication dose; Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C4019308
UMLS CUI [1,2]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Descripción

iodine-131-tositumomab; Medication dose

Tipo de datos

text

Unidades de medida
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Therapeutic Dose
Descripción

Therapeutic Dose

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0178602
Date Therapeutic Dose administered
Descripción

Date Therapeutic Dose administered

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Descripción

Actual Iodine-131 Anti-B1 Antibody dose administered

Tipo de datos

text

Unidades de medida
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Administrative
Descripción

Administrative

Alias
UMLS CUI-1
C1320722
Investigator Signature
Descripción

Investigator Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Date of evaluation
Descripción

Date of evaluation

Tipo de datos

date

Alias
UMLS CUI [1]
C2985720

Similar models

Actual administered mCi Dose

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Dosimetric Dose
C4019308 (UMLS CUI-1)
Medication dose; Date in time
Item
Date dose administered
date
C4019308 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
iodine-131-tositumomab; Medication dose
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Therapeutic Dose
C0087111 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
Date Therapeutic Dose administered
Item
Date Therapeutic Dose administered
date
C0087111 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Actual Iodine-131 Anti-B1 Antibody dose administered
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Administrative
C1320722 (UMLS CUI-1)
Investigator Signature
Item
Investigator Signature
text
C2346576 (UMLS CUI [1])
Date of evaluation
Item
Date of evaluation
date
C2985720 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial